Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/099269
Kind Code:
A1
Abstract:
Provided are following compound (I) or a pharmaceutically acceptable salt, ester, optical isomer, tautomer, stereoisomer, polymorph, solvate, N-oxide, isotope-labeled compound, metabolite, chelate, complex, inclusion compound or prodrug thereof, and a pharmaceutical composition comprising the compound. Further provided are a use of the compound as a potassium channel regulator, a use of the compound in preparation of a drug for diseases associated with a potassium channel, and a corresponding pharmaceutical composition.

Inventors:
YANG HUAIYU (CN)
YE YANGLIANG (CN)
WANG KUN (CN)
ZHANG SHAOYING (CN)
ZHANG QIANSEN (CN)
MO YIQING (CN)
MEI LIANGHE (CN)
Application Number:
PCT/CN2023/129942
Publication Date:
May 16, 2024
Filing Date:
November 06, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV EAST CHINA NORMAL (CN)
SUZHOU NEW DRUG INCUBATOR BIOPHARMACEUTICAL TECH CO LTD (CN)
International Classes:
C07D487/00; A61K31/165; A61K31/41; A61P25/08; C07C233/64
Attorney, Agent or Firm:
FIWIS INTELLECTUAL PROPERTY LAW FIRM (CN)
Download PDF: